Navigation Links
Union Equity, Inc.'s Wholly Owned Subsidiary Develops Cream that Aids in Soothing the Symptoms of Chemotherapy
Date:6/13/2012

ORLANDO, Fla., June 13, 2012 /PRNewswire/ -- Union Equity Inc. (OTC: UNQT) is pleased to announce that its wholly owned subsidiary, Natural Product Laboratories LLC, has developed Allevium, a creme that contains natural ingredients and plant extracts, which aids in soothing the effects of chemotherapy treatment. The Allevium compound targets damaged and irritated skin and promotes soothing repair for affected areas.*

Each year, 10.9 million people worldwide are diagnosed with cancer and this incidence is rising. This increase reflects the world's growing population and the fact that people are living longer, according to the New Zealand Dermatological Society (dermnetnz.org). Chemotherapy and radiation treatment are in many cases crucial components to cancer management, a treatment that itself does not come without side effects, as doctors and patients alike will see an increasing incidence of, among other unwanted effects, cancer treatment related skin toxicity. Chemotherapy and radiation may cause skin irritations, such as redness, peeling, itching and dryness. The skin may look as if it is sunburned or tanned, and acne issues may present themselves.

Union Equity's subsidiary Natural Product Laboratories announces today that it is beginning its initial product distribution of three different versions of its Allevium product: Allevium Intense Repair Creme, Allevium Daily Moisture Creme and Allevium Solor Protection SPF 30. The Allevium line's target market is anyone who is looking to soothe the burns, breakouts and skin irritation suffered from chemotherapy and radiation therapy.

"As a mother who had to watch her daughter go through cancer treatments that ravaged her skin, I am proud to offer her and others a solution that will relieve them of their skin irritations," stated Pat Landers, Assistant Director of Operations for Natural Product Laboratories LLC. "I know the pain families feel standing by helplessly, watching their loved ones suffer. Our chemist and micro-biologist have developed a formulation that combines natural vitamins and plant extracts, along with other reparative ingredients, that soothe and nurture damaged skin from any cause, but in particular  whose skin damage is a result of cancer related skin toxicity."

* The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and this product is not intended to diagnose, treat, cure, or prevent any disease.

To learn more about Natural Product Laboratories, please call the toll free number: 888-522-2550

To learn more about Union Equity Inc., please visit: www.unionequityinc.info

Follow Union Equity, Inc. on Twitter: http://twitter.com/#!/UNQT

About Natural Product Laboratories LLC:
The Natural Product Laboratories LLC (NPL) laboratory and production facility is located in Melbourne, Florida and is FDA regulated and certified as well as Green Seal approved to produce the highest quality skin-care, personal care, hair, pet, baby and sunscreen products. The Company specializes in formulizations of new product lines as well as reverse engineering existing products. The staff includes a licensed chemist and certified microbiologist, with over 25 years' combined experience. NPL's skilled production team and broad range of equipment allows them to accommodate almost any size order. Packaging capabilities include a wide range of sizes for both professional and retail use.

Safe Harbor Act:
This release includes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties including, but not limited to, the impact of competitive products, the ability to meet customer demand, the ability to manage growth, acquisitions of technology, equipment, or human resources, the effect of economic business conditions, and the ability to attract and retain skilled personnel. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.

Contact:
David Donlin
Cervelle Group
407-299-2377

 


'/>"/>
SOURCE Union Equity, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
2. Intravenous Remodulin Approved for the Treatment of Pulmonary Arterial Hypertension in Most of the European Union
3. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
4. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
5. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
6. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
7. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
8. AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
9. NASA develops super-black material that absorbs light across multiple wavelength bands
10. UCLA team develops highly efficient method for creating flexible, transparent electrodes
11. Ecology Coatings Develops Coatings Safe for Direct Contact with Food Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... , ... March 01, 2017 , ... ... will hold its annual technology show and open house, Southern Tech Fest, April ... from Okuma, Tsugami, Hardinge Group and Chiron and perform live metal cutting demonstrations ...
(Date:2/28/2017)... Columbia, MD (PRWEB) , ... ... ... Instruments, Inc. (Columbia, MD) and MIDI, Inc. (Newark, DE) have formed a ... dietary supplement, food science, forensics and renewable energy laboratories. These automated testing ...
(Date:2/28/2017)... MELBOURNE , Australien, 28. Februar 2017 ... tätiges, innovatives Unternehmen, Anbieter und strategischer Partner ... Lösungen für den Gesundheitsbereich, das individuelle Gesundheitsversorgung ... ITL Health Group (ITL) bekannt. ... weltweiten, einheitlichen Plans der neuen Markenidentität und ...
(Date:2/28/2017)... ... February 28, 2017 , ... Patient travel is ... expertise. Colpitts Clinical Trial Travel and Expense , a division of global ... need within the biotechnology and pharmaceutical industries in the United States, Europe, and ...
Breaking Biology Technology:
(Date:2/8/2017)... Report Highlights The global biosurgery market should ... 2016 at a compound annual growth rate (CAGR) of ... An overview of the global market for biosurgery. - ... and 2016, and projections of compound annual growth rates ... the basis of product type, source, application, and region. ...
(Date:2/7/2017)... 7, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... will present at the LEERINK Partners 6th Annual Global ... on Wednesday, February 15, 2017 at 10 a.m. Eastern ... presentation can be accessed at http://wsw.com/webcast/leerink28/zbh .  The ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):